EECP Ecosystem
📍 EECPLocator.com🏔️ EECP with Lodging🏥 Pop-Up Clinics📖 Patient Guide Free🔬 Clinical Evidence📚 Training Courses📖 EECPBook.com
Women's Health Series›01 · Fibromyalgia|02 · Autoimmune|03 · Raynaud's
Off-Label Use · Women's Health Series · Article 03

EECP for Raynaud's Syndrome:
Vasospasm, Nitric Oxide Deficiency & the Endothelial Fix

Raynaud's syndrome is a vasospasm disorder driven by endothelial dysfunction and nitric oxide deficiency. EECP directly restores nitric oxide production — the primary vasodilatory signal that prevents episodic vasospasm.

5–10%
Of women affected by Raynaud's
95%
Of scleroderma patients have Raynaud's
NO↓
Nitric oxide deficiency — the root cause
Off-Label
Use — not FDA-cleared for Raynaud's
The Condition

Raynaud's Is an Endothelial Problem

Raynaud's syndrome causes episodic vasospasm of the peripheral arteries — typically in the fingers and toes — in response to cold or emotional stress. The affected areas turn white (ischemia), then blue (cyanosis), then red (reperfusion) as blood flow is cut off and restored. It affects 5–10% of women and up to 95% of patients with scleroderma.

The underlying mechanism is endothelial dysfunction: the endothelium — the single-cell lining of blood vessels — fails to produce adequate nitric oxide, the primary vasodilatory and anti-vasospastic signal. Without sufficient nitric oxide, sympathetic vasoconstriction goes unchecked, and cold or stress triggers an exaggerated vasospastic response.

"Raynaud's phenomenon is an episodic vasospasm of the peripheral arteries driven by endothelial dysfunction and impaired nitric oxide production. Therapies that restore endothelial nitric oxide synthesis represent a rational treatment approach." — Raynaud's treatment literature

How EECP Helps

Four Mechanisms Relevant to Raynaud's

⚡
Nitric Oxide Restoration
Raynaud's is characterised by deficient nitric oxide production. EECP's pulsatile shear stress directly stimulates eNOS — the enzyme that produces nitric oxide — restoring the vasodilatory signal that prevents vasospasm.
🩸
Peripheral Blood Flow
EECP increases diastolic augmentation — blood pressure during the relaxation phase of the heartbeat — improving peripheral perfusion to the fingers, toes, and extremities most affected by Raynaud's.
🔧
Endothelial Repair
EECP stimulates endothelial progenitor cell mobilization, repairing the damaged vessel lining that underlies both primary and secondary Raynaud's. This is particularly relevant in scleroderma-associated Raynaud's.
🌡️
Sympathetic Tone Reduction
By improving endothelial function and nitric oxide availability, EECP reduces the sympathetic overactivation that triggers vasospasm in response to cold and stress — the primary Raynaud's trigger.
Common Questions

Frequently Asked Questions

EECP is an off-label treatment for Raynaud's syndrome with strong physiological rationale. Raynaud's is driven by endothelial dysfunction and impaired nitric oxide production — the same mechanisms EECP directly addresses. EECP has been cited in Raynaud's treatment literature as a potential therapy, and its vasodilatory mechanism is directly relevant to episodic vasospasm.

Raynaud's syndrome is caused by episodic vasospasm of the peripheral arteries, typically triggered by cold or stress. The underlying mechanism is endothelial dysfunction — the endothelium fails to produce adequate nitric oxide, allowing sympathetic vasoconstriction to go unchecked. Secondary Raynaud's (associated with autoimmune disease) involves additional immune-mediated endothelial damage.

EECP for Raynaud's syndrome is an off-label use and is generally not covered by insurance. Medicare and most commercial plans cover EECP only for its FDA-cleared cardiac indications. Out-of-pocket cost is typically $3,000–$6,000 for a full 35-session course.

EECP generates pulsatile shear stress that stimulates endothelial cells to produce nitric oxide — the primary vasodilator that is deficient in Raynaud's. Restoring nitric oxide production reduces the sympathetic overactivation that triggers vasospasm, improves baseline peripheral blood flow, and reduces the frequency and severity of Raynaud's episodes.

Find a Provider for Raynaud's →

Free Patient Guide

Not ready to search for a provider?
Get the free EECP Patient Guide first.

8 modules covering what EECP is, who it helps, how to find the right provider, and what to expect — including a section on EECP for Raynaud's and autoimmune vascular conditions.

No spam. Unsubscribe any time.